Both in Pharmaceuticals
Definium Therapeutics vs AbCellera Biologics
Over the past year DFTX returned +136.2% and ABCL returned +193.5%; their daily moves had a correlation of 0.31.
DFTX +136.2% ABCL +193.5%Growth of $1, one year, split-adjusted
| Metric | DFTX | ABCL |
|---|---|---|
| Price | $36.33 | $12.27 |
| Market cap | $4.88B | $3.98B |
| Today | −4.29% | −6.19% |
| 1 month | −3.4% | −11.8% |
| 6 months | +67.4% | +177.0% |
| Year to date | — | +258.8% |
| 1 year | — | +118.3% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −1368.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 60.1× |
| Net cash | $1.05B | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | 55.4% | 94.9% |
| Short % of float | 7.6% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).